SEC Info - Kirk Randal J - ‘SC 13D/A’ on 6/8/15 re: Ziopharm Oncology Inc

SEC Info℠

Home

Help

Please Sign In

Kirk Randal J – ‘SC 13D/A’ on 6/8/15 re: Ziopharm Oncology Inc

On: Monday, 6/8/15, at 9:26pm ET · As of: 6/9/15 · Accession #: 1140361-15-23569 · File #: 5-79364

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

 6/09/15  Kirk Randal J                     SC 13D/A               1:61K  Ziopharm Oncology Inc             Summit Fin’l Printing

Amendment to General Statement of Beneficial Ownership — Schedule 13D
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: SC 13D/A    Randal J Kirk Sc 13Da No7 6-4-2015 (Ziopharm        HTML     36K 
                          Oncology Inc)

Filing Submission 0001140361-15-023569 – SGML Text

Original SGML Text submitted by:	Broadridge Financial Solutions, Inc. (as Filing Agent)

To view the SGML, please refresh
this page.

↑Top

Kirk Randal J – ‘SC 13D/A’ on 6/8/15 re: Ziopharm Oncology Inc

On: Monday, 6/8/15, at 9:26pm ET · As of: 6/9/15 · Accession #: 1140361-15-23569 · File #: 5-79364

Previous ‘SC 13D’: ‘SC 13D’ on 3/20/15 · Next: ‘SC 13D/A’ on 7/27/15 · Latest: ‘SC 13D/A’ on 5/3/24

Amendment to General Statement of Beneficial Ownership — Schedule 13DFiling Table of Contents

To view the SGML, please refresh this page.

Amendment to General Statement of Beneficial Ownership — Schedule 13D
Filing Table of Contents

To view the SGML, please refresh
this page.